Drawing for KIOMEDINE

USPTO serial 79040678

KIOMEDINE

Reviewed by CopyMark Law Group

Reg. 3564818Status 707Registered
Filing date
Status date
Registration date
Jan 20, 2009
Examiner
OKEKE, BENJAMIN
Law office
—

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with KIOMEDINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina M. Licursi

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.600 Atlantic AvenueFederal Reserve PlazaBoston, MA 02210-2206

Goods and services

ClassDescriptionStatusFirst use
001Plant biopolymers, namely, chitin, chitosans, chitin-glucan and derivatives of these products, for industrial and scientific applicationsACTIVE—
005Pharmaceutical and veterinary preparations made from biopolymers, used with other compounds to treat bleeding, wound, tissue disorders, inflammative disorders, immune disorders, degenerative disorders, cancer, neurological disorders, eye disorders, infections, as cell culture media, as excipients for systems involving the controlled release of actives, and used as a biomaterial component of medical devices for the treatment of wounds and burns, used in wound management, haemostatic systems, surgical systems, ophthafmologic devices, tissue engineering devices, cartilage substitutes, bone substitutes, skin reconstruction devices, periodontal products, vascular systems, and used in drug delivery systems in nanoparticles, microspheres, solutions, hydrogels, used in oral delivery, local delivery, mucosal delivery, nasal delivery, ocular delivery, transdermal delivery, intratumoral deliveryACTIVE—
042[ Scientific and technological consulting and research services in the medical field, for the development of the formulation of medical devices and pharmaceutical systems ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 1, 2019INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Sep 28, 2019INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 28, 2019INPCINVALIDATION PROCESSED—
Sep 25, 2019INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 7, 2019NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 25, 2019NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jan 25, 201971.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Jan 18, 2019ES71TEAS SECTION 71 RECEIVED—
Jan 20, 2018REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jun 8, 2017RNWLINTERNATIONAL REGISTRATION RENEWED—
May 19, 2016ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Feb 6, 2015NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Feb 6, 2015C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
Feb 6, 2015APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 20, 2015ES75TEAS SECTION 71 & 15 RECEIVED—
Dec 4, 2014ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Nov 27, 2014CHLDCHANGE OF OWNER RECEIVED FROM IB—
May 28, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 5, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 15, 2011TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 4, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 4, 2009FIMPFINAL DISPOSITION PROCESSED—
Apr 20, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 20, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 4, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 15, 2008NPUBNOTICE OF PUBLICATION—
Sep 30, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 29, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 26, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 26, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 26, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 26, 2008ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Mar 31, 2008CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 28, 2008CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 20, 2008ACECAMENDMENT FROM APPLICANT ENTERED—
Mar 20, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 19, 2008ALIEASSIGNED TO LIE—
Mar 3, 2008MAILPAPER RECEIVED—
Sep 20, 2007RFNTREFUSAL PROCESSED BY IB—
Aug 31, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 31, 2007RFRRREFUSAL PROCESSED BY MPU—
Aug 31, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 30, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 17, 2007DOCKASSIGNED TO EXAMINER—
Aug 17, 2007NWAPNEW APPLICATION ENTERED—
Aug 16, 2007REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance